GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Dividend Payout Ratio

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Dividend Payout Ratio : 0.00 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Dividend Payout Ratio?

Jiangsu Hengrui Pharmaceuticals Co's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:600276' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.16   Max: 0.3
Current: 0.22


During the past 13 years, the highest Dividend Payout Ratio of Jiangsu Hengrui Pharmaceuticals Co was 0.30. The lowest was 0.07. And the median was 0.16.

SHSE:600276's Dividend Payout Ratio is ranked better than
72.2% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs SHSE:600276: 0.22

As of today (2024-04-27), the Dividend Yield % of Jiangsu Hengrui Pharmaceuticals Co is 0.35%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Jiangsu Hengrui Pharmaceuticals Co was 0.57%. The lowest was 0.11%. And the median was 0.21%.

Jiangsu Hengrui Pharmaceuticals Co's Dividends per Share for the months ended in Mar. 2024 was ¥0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Jiangsu Hengrui Pharmaceuticals Co was 71.00% per year. The lowest was 3.60% per year. And the median was 19.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Jiangsu Hengrui Pharmaceuticals Co Dividend Payout Ratio Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Dividend Payout Ratio Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.17 0.25 0.30 0.25

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.93 - - -

Competitive Comparison of Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio falls into.



Jiangsu Hengrui Pharmaceuticals Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.16/ 0.65
=0.25

Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.211
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Jiangsu Hengrui Pharmaceuticals Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Traded in Other Exchanges
N/A
Address
No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines